All Content

Besides the AIDS-related cancers such as Kaposi's sarcoma, HIV-positive patients are now surviving long enough to face the age-related increased risk of cancer that affects everyone else. How do they fare, compared to the non-HIV-infected population?

Neurological manifestations of HIV are at least as common as they were before the introduction of HAART. The challenge is that they are milder, and more difficult to recognize. But early treatment is essential.

(AUDIO) Antiviral drugs have reduced intrauterine transmission of HIV dramatically. But what are the effects on the pregnancy itself? Here an infectious diseases expert discusses the risks and the benefits.

(AUDIO) The HIV Medicine Association has released a document that identifies the key characteristics of a medical provider qualified to manage the long-term care of patients infected with HIV. Here the chair of the organization describes the qualifications and tells why they are important.

Managing chronic disease and HIV in the over-50 population leads to a high risk of adverse drug interactions. Here are the most common polypharmacy culprits for HIV patients, and tips for avoiding these dangerous mishaps.

Numerous short- and long-term adjustments are underway to address an anticipated shortage in HIV care clinicians. One of the important alternatives may be shifting more care to nurses.

Implementation of the Patient Protection and Affordable Care Act is largely good news for patients with HIV, many of whom have been denied coverage under preexisting condition clauses. However, some questions and some gaps in coverage remain to be addressed.

When the FDA approved pre-exposure prophylaxis for HIV prevention, observers wondered whether or not the strategy was cost effective. A study has now analyzed the question. Answer: It depends.

(AUDIO) How often should people be (re)tested for HIV? A pair of industrial efficiency experts looked at current HIV testing recommendations, and found them too conservative.

(AUDIO) For older as well as young patients, clinicians should be sure to test regularly for HIV as the CDC advises, says a researcher who tells in this interview how suspicions about the origin of AIDS and the involvement of government may discourage older people from being tested.

Cardiovascular disease is now the cause of death for 10% of HIV-positive patients. Why this happens and how to prevent or treat it remain unclear, but research presented at the CROI conference offers insights into potential solutions.

From remote villages in Kenya to large cities in the United States, mobile phones and smart phones are becoming tools to overcome some of the greatest challenges in HIV—prevention, screening, and treatment adherence.

Hospitals, clinics, and researchers are investigating how electronic health records and personal health records, portals that give patients access to records and health education, can be used to improve HIV screening and outcomes.

(AUDIO) Correctional institutions offer an excellent opportunity to discover and treat HIV infection, which is usually contracted before incarceration. How can physicians assure that care is just as good after these patients are released into the community?

Top recent reports in HIV/AIDS research include a better way to deliver a vaccine in developing countries, a more effective way to administer a preventive drug, and insights into the cause of neurocognitive deficits.